Rice Hall James & Associates’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
Rice Hall James & Associates's VCYT Position: Q3 2026 in Review
Rice Hall James & Associates reduced its Veracyte (VCYT) stake by 17% in Q3 2026, selling an estimated $780K and leaving 79,416 shares worth $3.66M. The position accounts for 0.19% of the portfolio, ranked #114.
Rice Hall James & Associates first reported a position in VCYT in Q3 2024 and has held it in 9 quarters since. The position peaked at $5.61M in Q2 2026. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.
- Rice Hall James & Associates held 79,416 shares of Veracyte worth $3.66M as of Q3 2026.
- Rice Hall James & Associates sold 16,170 Veracyte shares in Q3 2026, an estimated $780K.
- Veracyte made up 0.19% of Rice Hall James & Associates's portfolio in Q3 2026, its #114 holding.
- Rice Hall James & Associates first reported a position in Veracyte in Q3 2024 and has held it in 9 quarters since.
- Rice Hall James & Associates's Veracyte position peaked at $5.61M in Q2 2026.
- 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.
Based on Rice Hall James & Associates's 13F filing for Q3 2026, filed 16 Nov 2026.